# A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

> **NCT04647344** · PHASE1,PHASE2 · COMPLETED · sponsor: **Akeso** · enrollment: 46 (actual)

## Conditions studied

- Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV

## Interventions

- **DRUG:** AK104 plus Carboplatin and Pemetrexed
- **DRUG:** AK104 plus Carboplatin and paclitaxel

## Key facts

- **NCT ID:** NCT04647344
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-24
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647344, "A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04647344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*